| Product Code: ETC8282827 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Medical Contrast Agent Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Medical Contrast Agent Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Medical Contrast Agent Market - Industry Life Cycle |
3.4 Mexico Medical Contrast Agent Market - Porter's Five Forces |
3.5 Mexico Medical Contrast Agent Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Medical Contrast Agent Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 Mexico Medical Contrast Agent Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Mexico Medical Contrast Agent Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.9 Mexico Medical Contrast Agent Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Mexico Medical Contrast Agent Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases that require medical imaging procedures using contrast agents |
4.2.2 Growing demand for advanced diagnostic imaging technologies in Mexico |
4.2.3 Rise in healthcare infrastructure development and investments in the country |
4.3 Market Restraints |
4.3.1 High cost associated with contrast agents impacting affordability for patients |
4.3.2 Stringent regulations and approval processes for medical contrast agents in Mexico |
4.3.3 Limited awareness and education about the benefits of contrast-enhanced imaging among healthcare professionals and patients |
5 Mexico Medical Contrast Agent Market Trends |
6 Mexico Medical Contrast Agent Market, By Types |
6.1 Mexico Medical Contrast Agent Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Medical Contrast Agent Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mexico Medical Contrast Agent Market Revenues & Volume, By Barium based Contrast Media, 2021- 2031F |
6.1.4 Mexico Medical Contrast Agent Market Revenues & Volume, By Iodinated Contrast Media, 2021- 2031F |
6.1.5 Mexico Medical Contrast Agent Market Revenues & Volume, By Gadolinium based Contrast Media, 2021- 2031F |
6.1.6 Mexico Medical Contrast Agent Market Revenues & Volume, By Microbubble Contrast Media, 2021- 2031F |
6.2 Mexico Medical Contrast Agent Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Mexico Medical Contrast Agent Market Revenues & Volume, By X-ray or Computed Tomography, 2021- 2031F |
6.2.3 Mexico Medical Contrast Agent Market Revenues & Volume, By Magnetic Resonance Imaging, 2021- 2031F |
6.2.4 Mexico Medical Contrast Agent Market Revenues & Volume, By Ultrasound, 2021- 2031F |
6.3 Mexico Medical Contrast Agent Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mexico Medical Contrast Agent Market Revenues & Volume, By Oral Contrast Media, 2021- 2031F |
6.3.3 Mexico Medical Contrast Agent Market Revenues & Volume, By Injectable Contrast Media, 2021- 2031F |
6.3.4 Mexico Medical Contrast Agent Market Revenues & Volume, By Rectal Contrast Media, 2021- 2031F |
6.3.5 Mexico Medical Contrast Agent Market Revenues & Volume, By Urethral Contrast Media, 2021- 2031F |
6.4 Mexico Medical Contrast Agent Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 Mexico Medical Contrast Agent Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F |
6.4.3 Mexico Medical Contrast Agent Market Revenues & Volume, By Oncology, 2021- 2031F |
6.4.4 Mexico Medical Contrast Agent Market Revenues & Volume, By Gastrointestinal Disorders, 2021- 2031F |
6.4.5 Mexico Medical Contrast Agent Market Revenues & Volume, By Musculoskeletal Disorders, 2021- 2031F |
6.4.6 Mexico Medical Contrast Agent Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.4.7 Mexico Medical Contrast Agent Market Revenues & Volume, By Nephrological Disorders, 2021- 2031F |
6.5 Mexico Medical Contrast Agent Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Mexico Medical Contrast Agent Market Revenues & Volume, By Radiology, 2021- 2031F |
6.5.3 Mexico Medical Contrast Agent Market Revenues & Volume, By Interventional Radiology, 2021- 2031F |
6.5.4 Mexico Medical Contrast Agent Market Revenues & Volume, By Interventional Cardiology, 2021- 2031F |
7 Mexico Medical Contrast Agent Market Import-Export Trade Statistics |
7.1 Mexico Medical Contrast Agent Market Export to Major Countries |
7.2 Mexico Medical Contrast Agent Market Imports from Major Countries |
8 Mexico Medical Contrast Agent Market Key Performance Indicators |
8.1 Average number of contrast-enhanced imaging procedures conducted per month/year |
8.2 Adoption rate of advanced diagnostic imaging technologies in healthcare facilities |
8.3 Percentage of healthcare professionals trained in the use of contrast agents |
8.4 Patient satisfaction and feedback on the availability and quality of contrast-enhanced imaging services |
9 Mexico Medical Contrast Agent Market - Opportunity Assessment |
9.1 Mexico Medical Contrast Agent Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Medical Contrast Agent Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 Mexico Medical Contrast Agent Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Mexico Medical Contrast Agent Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.5 Mexico Medical Contrast Agent Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Mexico Medical Contrast Agent Market - Competitive Landscape |
10.1 Mexico Medical Contrast Agent Market Revenue Share, By Companies, 2024 |
10.2 Mexico Medical Contrast Agent Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |